Delivery Order SPE2DB20D3104-SPE2DB23FV6J9

Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trokendi XR 25 mg capsules. The $1,972.96 firm fixed price contract does not have a set-aside designation, indicating open competition. The award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,465.61, is for the supply of Trokendi XR 100 mg capsules. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC, valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,148.36 firm fixed-price contract is for the delivery of Trokendi XR 200 mg capsules. The award is not designated as a set-aside contract. The contract is issued under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,053.04, is a delivery order for the supply of Trokendi XR 100 mg capsules. The contract has a period of performance through February 24, 2025 and utilizes a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,613.68 firm fixed-price delivery order is for the supply of Trokendi XR 100 mg capsules, a specialty medication. The contract has a completion date of May 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,096.71 delivery order contract is for the supply of Trokendi XR 50 mg capsules, a specialty medication, to support military healthcare programs. The contract has a firm fixed price pricing type and a performance period through January 23, 2024. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $22,015.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Trokendi XR 200 mg capsules, a medication used for the treatment of various medical conditions. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $1,851.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trokendi XR 100 mg capsules, a specialty medication. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is August 20, 2024. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,766.23 firm fixed-price delivery order is for the supply of Trokendi XR 200 mg capsules, a medication used to treat certain types of seizures. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,276.89 firm fixed-price delivery order contract covers the supply of Trokendi XR 100 mg capsules to support federal healthcare programs. The contract is not designated as a set-aside award. It is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV6J9
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,631.52 firm fixed price contract is for the supply of Trokendi XR 25 mg capsules, with a period of performance through April 28, 2023.

AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies across various federal agencies and healthcare programs.

The contract award reviewed does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 11:21 AM